Search

everythinglearnresearchcommunity

for

Search:↓

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Histone demethylases can change gene expression and may be linked to diseases like cancer.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

The paper concludes that understanding melanocyte development can help in insights into skin diseases and melanoma diversity.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Human skin can make serotonin and melatonin.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

Erectile dysfunction is increasingly common in men under 40, with many physical and psychological causes, and various treatment options available.

CDP is crucial for lung and hair follicle cell development.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Children with atopic dermatitis often have sleep problems, affecting their growth and behavior.

Animals that change color with the seasons mainly do so in response to daylight changes, but climate change is causing camouflage problems that may require evolutionary changes.

Minoxidil effectively treats severe hypertension but may cause side effects, so careful monitoring is needed.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Kennedy's disease leads to muscle weakness and sensory issues, has no cure but manageable symptoms, and future treatments look promising.

The transscrotal testosterone patch normalizes hormone levels in men with AIDS and weight loss but does not improve weight, body mass, or quality of life.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

SHBG may be a useful early indicator and treatment target for PCOS.

DHT, a testosterone byproduct, causes male pattern baldness.

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

New treatments aim to improve thin endometrium to help more couples with infertility.